Russia Genetic Testing Market Outlook to 2021 GlobalData s new report, Russia Genetic Testing Market Outlook to 2021, provides key market data on the Russia Genetic Testing market. The report provides value, in millions of US dollars within market segments Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis. Scope Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests. Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. 2014 company shares and distribution shares data for Genetic Testing market. Global corporate-level profiles of key companies operating within the Russia Genetic Testing market. Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc. Reasons to buy Develop business strategies by identifying the key market segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register
strong growth in the near future. What are the key distribution channels and what s the most preferred mode of product distribution Identify, understand and capitalize. 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 3 2 Introduction 4 2.1 What Is This Report About? 4 2.2 Genetic Testing Market Segmentation 4 2.3 Definitions of Markets Covered in the Report 5 3 Genetic Testing Market, Russia 6 3.1 Genetic Testing Market, Russia, Revenue ($m), 2007-2014 6 3.2 Genetic Testing Market, Russia, Revenue ($m), 2014-2021 8 3.3 Genetic Testing Market, Russia, Distribution Share by Revenue ($m), 2013-2014 10 3.4 Genetic Testing Market, Russia, Company Share by Revenue ($m), 2014 11 4 Overview of Key Companies in Russia, Genetic Testing Market 13 4.1 F. Hoffmann-La Roche Ltd. 13 4.1.1 Company Overview 13 4.2 Hologic, Inc. 13 4.2.1 Company Overview 13 4.3 Danaher Corporation 13 4.3.1 Company Overview 13 4.4 Siemens Healthcare 14 4.4.1 Company Overview 14 4.5 PerkinElmer, Inc. 14 4.5.1 Company Overview 14 4.6 Abbott Laboratories 14 4.6.1 Company Overview 14 4.7 Transgenomic, Inc. 15 4.7.1 Company Overview 15 5 Genetic Testing Market Pipeline Products 16
6 Financial Deals Landscape 20 6.1 Asset Transactions 20 6.1.1 Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 20 6.2 Partnerships 22 6.2.1 KromaTiD Enters into Distribution Agreement with Tebu-bio 22 7 Appendix 23 7.1 Research Methodology 24 7.1.1 Coverage 24 7.1.2 Secondary Research 24 7.1.3 Primary Research 25 7.1.4 Company Share Analysis 25 7.1.5 Distribution Share Analysis 25 7.2 GlobalData Consulting 25 7.3 Contact Us 26 7.4 Disclaimer 26 1.1 List of Tables Table 1: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 7 Table 2: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 9 Table 3: Genetic Testing Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 10 Table 4: Genetic Testing Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 12 Table 5: Genetic Testing Market Pipeline Products 16 Table 6: Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 20 Table 7: KromaTiD Enters into Distribution Agreement with Tebu-bio 22 1.2 List of Figures Figure 1: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 6
Figure 2: Genetic Testing Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 8 Figure 3: Genetic Testing Market, Russia, Company Share (%) 2014 11 any Share (%) 2014 25 Access Report: http://www.gosreports.com/russia-genetic-testing-market-outlook-to-20 21/ Contacts us: Joanna Executive - International Business and partner Relations E-mail: info@gosreports.com Tel: 001-510-400-8520 Web: www.gosreports.com